Yutu Technology

What Yutu Technology does

Yutu Technology (钰兔科技集团有限公司) is an AI-driven medical device transformation ecosystem operator founded in October 2021 and registered in Lhasa, Tibet, with principal operations in Beijing's Yizhuang Economic and Technological Development Zone. The company serves Chinese medical device companies, top-tier Class A Grade III hospitals, universities, and individual medical device sales representatives by providing an integrated service stack that spans patent evaluation, clinical research organization (CRO), contract development and manufacturing (CDMO), marketing services (MSS), and AI-powered workflow automation. It explicitly targets the structural gap that China's medical research output conversion rate remains below 8%, far below developed-market levels, by packaging fragmented transformation activities into a one-stop offering.

The company's core technology is the YutuBang (钰兔帮) AI Medical Translation Super Brain platform, an intelligent-agent-based open platform that combines large language model capabilities with an aggregated proprietary dataset of over 100 million medical device industry data points spanning 105 countries and 130 million global patent records. Dozens of self-developed intelligent agents cover six industry scenarios — project library, medical-industrial fusion, supply chain, clinical registration, marketing, and financing — enabling capabilities such as 2-minute multi-dimensional patent valuation, automated supplier matching, and clinical pathway recommendation. The platform is supported by three complementary sub-platforms (Yizhuanbao for patent services, Yigongzhirong for medical-industrial integration, Yutu Broker for shared human resources) and five shared CDMO production bases in Suzhou, Changzhou, Zhuhai, Xi'an, and Nanjing. Yutu also develops its own proprietary medical devices (a domestically exclusive non-invasive vascular detection workstation, portable neurosurgical navigation, disposable fat micro-fragment extractor, and children's motor development system) under an "domestic/global exclusive" investment standard.

Yutu pursues a hybrid go-to-market combining direct enterprise sales to hospitals and medical device companies, self-service SaaS platform access, and a distributed channel of 108 city partners and over 10,000 registered medical device brokers spanning 60+ active Chinese cities. Revenue derives from five streams: patent technology services (one-time), professional CXO service fees (CRO/CDMO), SaaS subscriptions (YutuBang, Yizhuanbao, Yutu Broker), a freemium broker platform monetized via commissions, and proprietary medical device hardware sales. The company has raised tens of millions of RMB in a single Series A round led by Taizhou Xiuzhen Medical Health Industry Investment in August 2024, has been certified as a National High-Tech Enterprise, Beijing Sci-Tech SME, and Tibet Specialized/Refined/Innovative SME, and counts more than 2,300 enterprises and 600+ ecosystem partners on its platform.

Name

Yutu Technology

Legal name

钰兔科技集团有限公司

Website

https://yutumed.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Yutu Technology is an AI-powered medical device transformation ecosystem operator in China, offering CRO/CDMO services, AI patent evaluation, marketing networks, and shared manufacturing to medical device companies, top-tier hospitals, and 10,000+ medical device brokers across 60+ cities.

Ownership category

akta.pro rank

Product category

Medical Device CXO Services

NAICS

Scientific Research and Development Services (5417), Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112)

SIC

Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Clinical Trial Management Systems (CTMS) (HLACAOAD), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• Medical device CRO services
• Medical device CDMO services
• AI medical translation platform
• Medical patent technology services
• Medical device sales outsourcing

Headquarters

HQ city

Daxing

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Patent Technical Services (专利技术服务): One-stop medical patent application, evaluation, transaction, and conversion closed-loop services covering the full patent lifecycle from filing to commercial transaction.
2. CXO Services (CRO + CDMO): Comprehensive CRO (clinical trial + registration) and CDMO (contract manufacturing) services enabling medical device companies to reduce development costs and accelerate time-to-market.
3. Marketing Service System (MSS): Shared broker model + city partner network generates marketing services revenue through commissions on completed transactions, task-based fees, and platform subscription fees from enterprise clients.
4. AI Platform SaaS Subscriptions: Enterprise SaaS platform (钰兔帮, 医专宝, 钰兔经纪人) charges platform access and usage fees for medical device companies, hospitals, and individual brokers seeking to manage projects, transformations, and broker operations.
5. Own Medical Device Product Conversions: Company invests in and develops proprietary medical device products (e.g., fat micro-particle processor, CO2 angiography device, neurosurgical navigation) targeting Class III and II device registrations, generating product revenue upon commercialization.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Yutu Technology provides comprehensive CXO services for medical device enterprises — including CRO (clinical trials and registration), CDMO (contract manufacturing across five shared production bases), MSS (marketing and sales outsourcing), and patent technology services — delivered through its AI-powered YutuBang platform and supported by a nationwide network of 10,000+ brokers and 108 city partners. The company also develops and registers proprietary innovative Class II/III medical devices (non-invasive vascular detection workstation, portable neurosurgical navigation system, single-use autologous fat micro-fragment extractor, smart IV infusion monitoring, CO2 angiography device, and pituitary tumor/breast molecular probes).

Product overview

Yutu Technology operates as an AI medical research achievement transformation ecosystem operator, offering a platform-plus-modules architecture centered on the YutuBang AI platform. The core YutuBang platform functions as an AI 'super brain' for medical device transformation, integrating multiple intelligent agents across project library, medical-industrial fusion, supply chain, clinical registration, marketing, and financing scenarios. The ecosystem is supported by specialized platforms including Yizhuanbao (medical patent services), Yigongzhirong (medical-industrial integration), and Yutu Broker (shared human resources), alongside a full suite of CXO services (CRO, CDMO, MSS) for clinical trials, manufacturing, and marketing. The company also develops proprietary innovative medical devices including a non-invasive vascular detection workstation (domestically exclusive), a portable neurosurgical navigation system, and a disposable fat micro-fragment extractor (globally leading). The overall architecture combines an AI-powered digital platform with offline service capabilities across five shared CDMO production bases in Suzhou, Changzhou, Zhuhai, Xi'an, and Nanjing.

Differentiator

Problem solved

Functional benefit

Brands

• 脉全无创血管检测工作站: Domestic exclusive non-invasive vascular detection workstation
• 便携式智能化神经外科手术导航系统
• 儿童运动发展辅助评估与促进系统
• 一次性使用自体脂肪微片段提取器

Products and services

• YutuBang (钰兔帮) AI Medical Transformation Super-Brain Platform AI super-brain platform for medical device transformation providing one-stop intelligent agent workflows across project library, medical-industrial fusion, supply chain, clinical registration, marketing, and financing scenarios for medical device companies, hospitals, and research institutions.
• Yigongzhirong (医工智融) Medical-Industrial Integration Platform A medical-industrial integration platform serving as a production-education-research fusion base that connects medical professionals with engineering and industrial resources to facilitate cross-disciplinary collaboration in medical device innovation.
• Yizhuanbao (医专宝) Medical Patent Services Platform Specialized platform providing medical patent application, evaluation, transaction, and transformation services, including AI-powered patent scientific assessment covering clinical, technical, registration, and market value dimensions. Backed by a global medical patent database covering 105 countries with 130M+ patent records.
• Yutu Broker (钰兔经纪人) Shared HR/Broker Platform A shared human resources service platform for the medical device industry that enables medical device professionals to monetize their resources by taking on flexible tasks and earning commissions online. The platform hosts 10,000+ registered medical device sales representatives.
• CRO (Clinical Research Organization) Services Professional clinical trial services and medical device registration certificate application services that help enterprises reduce transformation barriers and effectively improve clinical-to-registration efficiency for medical device declarations.
• CDMO (Contract Development and Manufacturing Organization) Services Customized contract manufacturing services utilizing a shared production platform across five industrial parks (Suzhou, Changzhou, Zhuhai, Xi'an, Nanjing) and multiple product lines, helping medical device clients reduce upfront investment and shorten production cycles.
• MSS (Marketing Sales Service) Marketing services using a shared broker plus city partner model to build a national channel network for medical device products, completing marketing service closure and improving career ecology for industry talent.
• Patent Technology Services (专利技术服务) One-stop medical patent application, evaluation, transaction, and transformation closed-loop services, with access to a global medical patent database covering 105 countries with 130M+ patent records.
• VascularCheck Non-invasive Vascular Detection Workstation (脉全无创血管检测工作站) A proprietary domestically-exclusive non-invasive vascular detection workstation providing comprehensive vascular health assessment.
• Portable Intelligent Neurosurgical Navigation System (便携式智能化神经外科手术导航系统) A portable intelligent neurosurgical navigation system developed as an innovative medical device with proprietary invention patents for precision surgical guidance in neurosurgery.
• Children's Motor Development Auxiliary Assessment and Promotion System (儿童运动发展辅助评估与促进系统) A domestically-exclusive system for auxiliary assessment and promotion of children's motor development, designed to support pediatric rehabilitation and developmental monitoring.
• Disposable Autologous Fat Micro-fragment Extractor (一次性使用自体脂肪微片段提取器) A globally-leading single-use disposable device for extracting autologous fat micro-fragments, used in aesthetic and regenerative medicine applications.

Quantifiable outcome

• Patent evaluation completed in 2 minutes via AI system
• +3 more outcomes

Named customers13 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability8 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered core, major and minor.

• 中国医药卫生文化协会医工融合分会 (China Medical Health Culture Association Medical-Engineering Fusion Branch)coreStrategic or Co-development Partner · 1 December 2023Deep strategic partnership including joint construction of a medical-engineering fusion technology talent and exchange platform. The branch elected Yutu's CEO as Vice President. Both parties collaborate on talent cultivation bridging medicine and engineering disciplines, and co-organize academic conferences.
• 福州大学 & 福建医科大学 (Fuzhou University & Fujian Medical University)majorStrategic or Co-development Partner · 1 December 2023Co-hosts of the China Medical Health Culture Association Medical-Engineering Fusion Branch 2023 Academic Annual Conference. Both institutions collaborate with Yutu in the broader medical-engineering fusion innovation ecosystem.
• 北京大学第一医院 (Peking University First Hospital)coreStrategic or Co-development Partner · 1 December 2022Signed medical patent transformation agreement to jointly promote basic research to clinical translation. The hospital is a Class A Grade III comprehensive hospital with 19 national key clinical specialties. Yutu provides full-cycle transformation services from patent evaluation to commercialization.
• 北京协和医院 (Beijing Union Medical College Hospital)coreStrategic or Co-development Partner · 1 January 2021One of China's top Class A Grade III hospitals. Listed as a key partner in the medical device transformation ecosystem, collaborating on product co-development and clinical application of innovative medical devices.
• 北京安贞医院 (Beijing Anzhen Hospital)coreStrategic or Co-development PartnerKey cardiovascular and thoracic surgery hospital. Partner in medical device transformation ecosystem for collaborative product development and clinical application.
• 北京天坛医院 (Beijing Tiantan Hospital)coreStrategic or Co-development PartnerPremier neurosurgery and neurology hospital. Partner in medical device transformation ecosystem for neurosurgical navigation and related device development.
• 北京理工大学 (Beijing Institute of Technology)majorTechnology or IntegrationListed as a university partner providing engineering and technology expertise for medical-engineering fusion projects. Bridges the gap between medical research and engineering implementation.
• 石家庄市投促局 (Shijiazhuang Investment Promotion Bureau)minorOthersGovernment investment promotion bureau visited Yutu to understand the company's medical research transformation layout, explore cooperation possibilities, and promote medical transformation development. Not a formal commercial partnership.
• 德瑞医疗, 劢迪可可, 医路通检测, 钰犸生物, 北京同仁堂 (Derui Medical, Maidi Coco, Yilutong Testing, Yuma Biology, Beijing Tongrentang)minorOthersListed as ecosystem partners within the broader 600+ industry partner network. Nature of partnerships includes supply chain, distribution, and healthcare services.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• WuXi AppTec: Global CRO/CDMO leader with comprehensive preclinical, clinical, and manufacturing services across pharma and medical devices. Most relevant as a scaled incumbent that dwarfs Yutu in headcount, geographic reach, and trial capabilities, though WuXi is pharma-centric rather than device-centric.
• Hangzhou Tigermed: Leading Chinese clinical CRO providing Phase I-IV clinical trial services and medical device clinical research. Directly comparable as a Chinese CRO serving both pharma and medical device sponsors, with established investigator networks and full-service capabilities.
• Asymchem Laboratories: Chinese CDMO providing API and formulation development and manufacturing. Comparable on the CDMO side of Yutu's CXO offering, though focused on small-molecule pharma rather than medical devices.
• Pharmaron: Integrated CRO/CDMO offering laboratory, CMC, clinical, and manufacturing services across global pharma and biotech. Comparable as a one-stop CRO/CDMO, though again weighted toward pharma rather than medical devices.
• Mindray: Leading Chinese medical device manufacturer with broad product portfolio across patient monitoring, IVD, and imaging. Comparable as a successful Chinese medtech innovator that has scaled from domestic to global markets — a potential long-term template for Yutu's own-device pipeline.
• United Imaging Healthcare: Chinese high-end medical imaging and radiotherapy device company with strong R&D and global commercialization. Comparable as a Chinese medtech player that combines proprietary device innovation with hospital channel access.
• Lepu Medical: Chinese medical device company with cardiovascular, IVD, and interventional products. Comparable as a Chinese medtech with proprietary device IP and hospital sales channels that Yutu's transformation ecosystem aims to support.

Direct peers

• Topchoice Medical (鼎晖医疗/Topchoice): Chinese medical device CRO/CDMO providing clinical trial, registration, and commercialization services specifically for medical devices. Most directly comparable to Yutu's CRO/CDMO core, though smaller scale and less AI-enabled platform.

Emerging players

• Sonoscape: Chinese medical device company with focus on ultrasound and endoscopy products. Comparable as a Chinese medtech innovator that has used clinical-hospital partnerships to commercialize proprietary device IP.
• Yidu Tech: Chinese AI-in-healthcare company applying big data and AI to clinical decision support, drug R&D, and hospital operations. Comparable as a Chinese healthtech applying AI/data to clinical and life-science workflows, with overlapping investor interest in AI-enabled life science services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yutu Technology